UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)

European urology, 2001-11, Vol.40 (5), p.576-588

2001

Link zum Volltext

Verfügbarkeit prüfen

Which fluoroquinolones are suitable for the treatment of urinary tract infections?

International journal of antimicrobial agents, 2001-04, Vol.17 (4), p.331-341

2001

Link zum Volltext

Verfügbarkeit prüfen

Concentrations of Gatifloxacin in Plasma and Urine and Penetration into Prostatic and Seminal Fluid, Ejaculate, and Sperm Cells after Single Oral Administrations of 400 Milligrams to Volunteers

Antimicrobial Agents and Chemotherapy, 2001-01, Vol.45 (1), p.293-297

2001

Link zum Volltext

Verfügbarkeit prüfen

Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections

International journal of antimicrobial agents, 2004-03, Vol.23, p.41-53

2004

Link zum Volltext

Verfügbarkeit prüfen

Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose

International journal of antimicrobial agents, 2004-03, Vol.23, p.6-16

2004

Link zum Volltext

Verfügbarkeit prüfen

Recurrent urinary tract infection in women

International journal of antimicrobial agents, 2001-04, Vol.17 (4), p.259-268

2001

Link zum Volltext

Verfügbarkeit prüfen

Catheter-associated urinary tract infections

International journal of antimicrobial agents, 2001-04, Vol.17 (4), p.299-303

2001

Link zum Volltext

Verfügbarkeit prüfen

Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000

International journal of antimicrobial agents, 2002-06, Vol.19 (6), p.557-564

2002

Link zum Volltext

Verfügbarkeit prüfen

Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections

International journal of antimicrobial agents, 2004-06, Vol.23 (6), p.596-605

2004

Link zum Volltext

Verfügbarkeit prüfen

Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology

International journal of antimicrobial agents, 2000-08, Vol.15 (3), p.207-211

2000

Link zum Volltext

Verfügbarkeit prüfen

Classification of fluoroquinolones

International journal of antimicrobial agents, 1998-11, Vol.10 (4), p.255-257

1998

Link zum Volltext

Verfügbarkeit prüfen

Urinary tract infection in adults: research priorities and strategies

International journal of antimicrobial agents, 2001-04, Vol.17 (4), p.343-348

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Bacterial Urinary Tract Infections: Presence and Future

European urology, 2006-02, Vol.49 (2), p.235-244

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the phytotherapeutic drug Canephron reg; N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia

Research and reports in urology, 2013-02, Vol.2013 (default), p.39-46

Naber KG

2013

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections

International journal of antimicrobial agents, 2000-11, Vol.16 (3), p.239-243

2000

Link zum Volltext

Verfügbarkeit prüfen

Current challenges in the treatment of complicated urinary tract infections and prostatitis

Clinical microbiology and infection, 2006-05, Vol.12 (s3), p.67-80

2006

Link zum Volltext

Verfügbarkeit prüfen

Urinary tract infections in adults with diabetes

International journal of antimicrobial agents, 2001-04, Vol.17 (4), p.287-292

2001

Link zum Volltext

Verfügbarkeit prüfen

Urinary Excretion and Bactericidal Activities of a Single Oral Dose of 400 Milligrams of Fleroxacin versus a Single Oral Dose of 800 Milligrams of Pefloxacin in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1659-1665

1998

Link zum Volltext

Verfügbarkeit prüfen

EAU Guidelines for the Management of Genitourinary Tuberculosis

European urology, 2005-09, Vol.48 (3), p.353-362

2005

Link zum Volltext

Verfügbarkeit prüfen

Evaluation by Monte Carlo Simulation of the Pharmacokinetics of Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2005-05, Vol.49 (5), p.1881-1889

2005

Link zum Volltext

Verfügbarkeit prüfen

Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany

European journal of clinical microbiology & infectious diseases, 2005-06, Vol.24 (6), p.419-422

2005

Link zum Volltext

Verfügbarkeit prüfen

Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections

Drugs (New York, N.Y.), 2004-01, Vol.64 (12), p.1359-1373

2004

Link zum Volltext

Verfügbarkeit prüfen

Catheter associated urinary tract infection and encrustation

International journal of antimicrobial agents, 2001-04, Vol.17 (4), p.305-310

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment options for acute uncomplicated cystitis in adults

Journal of antimicrobial chemotherapy, 2000-08, Vol.46 (suppl-1), p.23-27

Naber, KG

2000

Link zum Volltext

Verfügbarkeit prüfen

Progress in the management of urinary tract infections: discussion

Journal of antimicrobial chemotherapy, 2000-08, Vol.46 (suppl-1), p.63-65

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(143)
Tagungsberichte
(9)

Sprache

Englisch
(143)
Japanisch
(11)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(131)
Humans
(112)
Infectious Diseases
(81)
Pharmacology & Pharmacy
(75)
Male
(68)
Microbiology
(66)
Biological And Medical Sciences
(59)
Medical Sciences
(59)
Pharmacology. Drug Treatments
(50)
Female
(49)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(46)
Urinary Tract Infections - Drug Therapy
(45)
Antibacterial Agents
(42)
Adult
(39)
Urinary Tract Infections - Microbiology
(36)
Urology & Nephrology
(25)
Middle Aged
(23)
Aged
(21)
Microbial Sensitivity Tests
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)

Which fluoroquinolones are suitable for the treatment of urinary tract infections?

Concentrations of Gatifloxacin in Plasma and Urine and Penetration into Prostatic and Seminal Fluid, Ejaculate, and Sperm Cells after Single Oral Administrations of 400 Milligrams to Volunteers

Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections

Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose

Recurrent urinary tract infection in women

Catheter-associated urinary tract infections

Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000

Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections

Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology

Classification of fluoroquinolones

Urinary tract infection in adults: research priorities and strategies

Treatment of Bacterial Urinary Tract Infections: Presence and Future

Efficacy and safety of the phytotherapeutic drug Canephron reg; N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia

In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections

Current challenges in the treatment of complicated urinary tract infections and prostatitis

Urinary tract infections in adults with diabetes

Urinary Excretion and Bactericidal Activities of a Single Oral Dose of 400 Milligrams of Fleroxacin versus a Single Oral Dose of 800 Milligrams of Pefloxacin in Healthy Volunteers

EAU Guidelines for the Management of Genitourinary Tuberculosis

Evaluation by Monte Carlo Simulation of the Pharmacokinetics of Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Healthy Volunteers

Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany

Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections

Catheter associated urinary tract infection and encrustation

Treatment options for acute uncomplicated cystitis in adults

Progress in the management of urinary tract infections: discussion

Suchergebnisse filtern